|  | NEAP (mEq/day) | P | |
---|---|---|---|---|
< 50.1 (n = 50) (25.6–50.1) | ≥50.1 (n = 45) (50.8–79.2) | |||
Sex (Male) | n (%) | 22 (44.0) | 34 (75.6) | 0.004 |
Age | years | 66.7 ± 11.6 | 64.8 ± 11.1 | 0.427 |
BMI | kg/m2 | 24.8 ± 4.7 | 24.8 ± 4.4 | 0.980 |
eGFR | ml/min/1.73 m2 | 63.4 ± 17.2 | 63.0 ± 21.5 | 0.908 |
Creatinine | mg/dl | 0.9 ± 0.3 | 1.0 ± 0.4 | 0.095 |
CKD stage 1 | n (%) | 2 (4.0) | 4 (8.9) | 0.799 |
CKD stage 2 | n (%) | 29 (58.0) | 24 (53.3) | |
CKD stage 3 | n (%) | 16 (32.0) | 14 (31.1) | |
CKD stage 4 | n (%) | 3 (6.0) | 3 (6.7) | |
Proteinuria | n (%) | 21 (42.0) | 26 (57.8) | 0.183 |
Diabetes | n (%) | 36 (72.0) | 25 (55.6) | 0.146 |
Nutrition education | n (%) | 6 (12.0) | 8 (17.8) | 0.615 |
Hyperkalemia | n (%) | 4 (8.0) | 1 (2.2) | 0.424 |
Serum uric acid | mg/dl | 5.5 ± 1.6 | 5.8 ± 1.4 | 0.391 |
Serum electrolytes | ||||
 K | mEq/L | 4.2 ± 0.4 | 4.1 ± 0.3 | 0.683 |
 Na | mEq/L | 139.4 ± 2.6 | 140.3 ± 1.5 | 0.037 |
 Cl | mEq/L | 102.9 ± 3.0 | 104.0 ± 2.2 | 0.048 |
NEAP | mEq/day | 39.5 ± 6.7 | 61.9 ± 6.8 | < 0.001 |